Fatal Yellow Fever in Travelers to Brazil, 2018

Guardado en:
Detalles Bibliográficos
Publicado en:MMWR. Morbidity and Mortality Weekly Report vol. 67, no. 11 (Mar 23, 2018), p. 340
Autor principal: Hamer, Davidson H, MD
Otros Autores: Angelo, Kristina, DO, Caumes, Eric, MD, van Genderen, Perry J J, MD, PhD, Florescu, Simin A, MD, PhD, Popescu, Corneliu P, MD, Perret, Cecilia, MD, McBride, Angela, BMBS, Checkley, Anna, MBChB, DPhil, Ryan, Jenny, MBBS, Cetron, Martin, MD, Schlagenhauf, Patricia, PhD
Publicado:
U.S. Center for Disease Control
Materias:
Acceso en línea:Citation/Abstract
Full Text
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nab a2200000uu 4500
001 2021241060
003 UK-CbPIL
022 |a 0149-2195 
022 |a 1545-861X 
022 |a 0091-0031 
035 |a 2021241060 
045 0 |b d20180323 
084 |a 15976  |2 nlm 
100 1 |a Hamer, Davidson H, MD 
245 1 |a Fatal Yellow Fever in Travelers to Brazil, 2018 
260 |b U.S. Center for Disease Control  |c Mar 23, 2018 
513 |a Feature 
520 3 |a Yellow fever virus is a mosquito-borne flavivirus that causes yellow fever, an acute infectious disease that occurs in South America and sub-Saharan Africa. Most patients with yellow fever are asymptomatic, but among the 15% who develop severe illness, the case fatality rate is 20%-60%. Effective live-attenuated virus vaccines are available that protect against yellow fever. An outbreak of yellow fever began in Brazil in December 2016; since July 2017, cases in both humans and nonhuman primates have been reported from the states of Sao Paulo, Minas Gerais, and Rio de Janeiro, including cases occurring near large urban centers in these states. Yellow fever is a potentially fatal illness that is preventable by vaccination. Yellow fever vaccination is recommended for all eligible persons aged ≥9 months, traveling to many areas in Brazil, including the states of Sao Paulo and Rio de Janeiro (especially Ilha Grande). 
610 4 |a Boston University International Society of Travel Medicine Public Health England World Health Organization University of Zurich Boston Medical Center Pontificia Universidad Catolica de Chile Food & Drug Administration--FDA University College London Hospitals Department of Health & Human Services 
651 4 |a Ilha Grande 
651 4 |a United Kingdom--UK 
651 4 |a Peru 
651 4 |a Africa 
651 4 |a Argentina 
651 4 |a Brazil 
651 4 |a Rio de Janeiro Brazil 
651 4 |a France 
651 4 |a Atlanta Georgia 
651 4 |a Switzerland 
651 4 |a Netherlands 
651 4 |a United States--US 
651 4 |a New York 
651 4 |a Massachusetts 
651 4 |a Romania 
651 4 |a South America 
651 4 |a Chile 
653 |a Vaccines 
653 |a Flavivirus 
653 |a Fever 
653 |a Viruses 
653 |a Outbreaks 
653 |a Immunization 
653 |a Primates 
653 |a Urban environments 
653 |a Travel 
653 |a Tropical diseases 
653 |a Infectious diseases 
653 |a Urban areas 
653 |a Vector-borne diseases 
653 |a Illnesses 
653 |a Avoidable 
653 |a Mosquitoes 
653 |a Yellow fever 
653 |a Patients 
700 1 |a Angelo, Kristina, DO 
700 1 |a Caumes, Eric, MD 
700 1 |a van Genderen, Perry J J, MD, PhD 
700 1 |a Florescu, Simin A, MD, PhD 
700 1 |a Popescu, Corneliu P, MD 
700 1 |a Perret, Cecilia, MD 
700 1 |a McBride, Angela, BMBS 
700 1 |a Checkley, Anna, MBChB, DPhil 
700 1 |a Ryan, Jenny, MBBS 
700 1 |a Cetron, Martin, MD 
700 1 |a Schlagenhauf, Patricia, PhD 
773 0 |t MMWR. Morbidity and Mortality Weekly Report  |g vol. 67, no. 11 (Mar 23, 2018), p. 340 
786 0 |d ProQuest  |t Healthcare Administration Database 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/2021241060/abstract/embedded/CH9WPLCLQHQD1J4S?source=fedsrch 
856 4 0 |3 Full Text  |u https://www.proquest.com/docview/2021241060/fulltext/embedded/CH9WPLCLQHQD1J4S?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/2021241060/fulltextPDF/embedded/CH9WPLCLQHQD1J4S?source=fedsrch